SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

42 hedge funds and large institutions have $157M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.61M
2 +$677K
3 +$329K
4
State Street
State Street
Massachusetts
+$250K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$242K

Top Sellers

1 -$832K
2 -$427K
3 -$193K
4
Goldman Sachs
Goldman Sachs
New York
-$189K
5
SIM
Spark Investment Management
New York
-$160K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$58.4M
2
$42.6M
3
$22M
4
$11.5M
5
$6.18M
6
$2.49M
7
$2.21M
8
$1.82M
9
$1.75M
10
$1.57M
11
$1.38M
12
$773K
13
$596K
14
$578K
15
$554K
16
$435K
17
$430K
18
$377K
19
$329K
20
$198K
21
$170K
22
$117K
23
$113K
24
$61K
25
$60K